See All Slides -

Slides

Presentation TCT 2020

Closure of Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Repair – The Randomized MITHRAS Trial

Presenter: Philipp Lurz

October 15, 2020

Presentation TCT 2020

In My Opinion: How Should Revascularization Guidelines Change After ISCHEMIA?

Presenter: Davide Capodanno

October 15, 2020

Presentation TCT 2020

Transcatheter Tricuspid Valve Replacement 2.0 (VDyne)

Presenter: Azeem Latib

October 15, 2020

Presentation TCT 2020

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

Presenter: Jeffrey W. Moses

October 15, 2020

Presentation TCT 2020

ISCHEMIA in Perspective: Updated Meta-Analysis on PCI in SIHD

Presenter: Sripal Bangalore

October 15, 2020

Presentation TCT 2020

Natural Vascular Scaffolding for PVD Interventions (Alucent)

Presenter: Myles Greenberg

October 15, 2020

Presentation TCT 2020

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Presenter: Corrado Tamburino

October 15, 2020

Presentation TCT 2020

Critical Analysis and Clinical Implications From ISCHEMIA

Presenter: David Maron

October 15, 2020

Presentation TCT 2020

Yes! With the Right Training, Everyone Can (and Should) Do CTO PCI!

Presenter: Simon Walsh

October 15, 2020

Presentation TCT 2020

A Universal Nomenclature for CTO Terminology and Standardization of CTO PCI Trials: Introduction to CTO-ARC

Presenter: Luiz Ybarra

October 15, 2020

Advertisement

Slides

Closure of Iatrogenic Atrial Septal Defects Following Transcatheter Mitral Valve Repair – The Randomized MITHRAS Trial

In My Opinion: How Should Revascularization Guidelines Change After ISCHEMIA?

Transcatheter Tricuspid Valve Replacement 2.0 (VDyne)

A Randomized Evaluation oF the TriGUARD3™ Cerebral Embolic Protection Device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation The REFLECT II Trial

ISCHEMIA in Perspective: Updated Meta-Analysis on PCI in SIHD

Natural Vascular Scaffolding for PVD Interventions (Alucent)

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Critical Analysis and Clinical Implications From ISCHEMIA

Yes! With the Right Training, Everyone Can (and Should) Do CTO PCI!

A Universal Nomenclature for CTO Terminology and Standardization of CTO PCI Trials: Introduction to CTO-ARC

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content